RARITAN, NJ--(Marketwired - Jun 21, 2016) - Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, announced that its VITROS ® Immunodiagnostic Products HIV Combo Reagent Pack ...

Raritan’s Ortho Clinical Diagnostics Holdings plc and Quidel Corp., based in San Diego, on Dec. 23 announced entering a definitive agreement that will see Quidel acquire Ortho in a deal valued at ...

RARITAN, N.J., July 7, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play, in-vitro diagnostics (IVD) companies, today announced its distribution agreement ...

- Ortho's new VITROS ® Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which gives clinicians ...

EYSINS, SWITZERLAND and RARITAN, NJ--(Marketwired - Jun 20, 2017) - Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, and Ortho Clinical Diagnostics ("Ortho"), a global leader ...

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and EKF Diagnostics (EKF) today announced an agreement that allows Ortho customers to access to Beta-Hydroxybutyrate (BHB) ...

RARITAN, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics (IVD) companies dedicated to transforming patient ...

Michael Iskra, executive vice president of commercial excellence and strategy at Ortho, said his company is focused on delivering quality results and the operational financial impacts of diagnostic ...

Raritan-based Ortho Clinical Diagnostics, a provider of in vitro diagnostics, announced its board of directors appointed Chris Smith as chief executive officer effective Sept. 9th. Smith will succeed ...